Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Primers
1.2.3 Probes
1.2.4 Intermediate-scale Synthesis Oligos
1.2.5 Large-scale Synthesis Oligos
1.2.6 Linkers and Adaptors
1.3 Market by Application
1.3.1 Global Solid-phase Oligonucleotide Synthesis Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Commercial
1.3.3 Academic Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Solid-phase Oligonucleotide Synthesis Market Perspective (2018-2033)
2.2 Solid-phase Oligonucleotide Synthesis Growth Trends by Region
2.2.1 Global Solid-phase Oligonucleotide Synthesis Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Solid-phase Oligonucleotide Synthesis Historic Market Size by Region (2018-2023)
2.2.3 Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Region (2024-2033)
2.3 Solid-phase Oligonucleotide Synthesis Market Dynamics
2.3.1 Solid-phase Oligonucleotide Synthesis Industry Trends
2.3.2 Solid-phase Oligonucleotide Synthesis Market Drivers
2.3.3 Solid-phase Oligonucleotide Synthesis Market Challenges
2.3.4 Solid-phase Oligonucleotide Synthesis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Solid-phase Oligonucleotide Synthesis Players by Revenue
3.1.1 Global Top Solid-phase Oligonucleotide Synthesis Players by Revenue (2018-2023)
3.1.2 Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Players (2018-2023)
3.2 Global Solid-phase Oligonucleotide Synthesis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Solid-phase Oligonucleotide Synthesis Revenue
3.4 Global Solid-phase Oligonucleotide Synthesis Market Concentration Ratio
3.4.1 Global Solid-phase Oligonucleotide Synthesis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Solid-phase Oligonucleotide Synthesis Revenue in 2022
3.5 Solid-phase Oligonucleotide Synthesis Key Players Head office and Area Served
3.6 Key Players Solid-phase Oligonucleotide Synthesis Product Solution and Service
3.7 Date of Enter into Solid-phase Oligonucleotide Synthesis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Solid-phase Oligonucleotide Synthesis Breakdown Data by Type
4.1 Global Solid-phase Oligonucleotide Synthesis Historic Market Size by Type (2018-2023)
4.2 Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Type (2024-2033)
5 Solid-phase Oligonucleotide Synthesis Breakdown Data by Application
5.1 Global Solid-phase Oligonucleotide Synthesis Historic Market Size by Application (2018-2023)
5.2 Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Solid-phase Oligonucleotide Synthesis Market Size (2018-2033)
6.2 North America Solid-phase Oligonucleotide Synthesis Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Solid-phase Oligonucleotide Synthesis Market Size by Country (2018-2023)
6.4 North America Solid-phase Oligonucleotide Synthesis Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Solid-phase Oligonucleotide Synthesis Market Size (2018-2033)
7.2 Europe Solid-phase Oligonucleotide Synthesis Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Solid-phase Oligonucleotide Synthesis Market Size by Country (2018-2023)
7.4 Europe Solid-phase Oligonucleotide Synthesis Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size (2018-2033)
8.2 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Region (2018-2023)
8.4 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Solid-phase Oligonucleotide Synthesis Market Size (2018-2033)
9.2 Latin America Solid-phase Oligonucleotide Synthesis Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country (2018-2023)
9.4 Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size (2018-2033)
10.2 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Country (2018-2023)
10.4 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Genescript
11.1.1 Genescript Company Detail
11.1.2 Genescript Business Overview
11.1.3 Genescript Solid-phase Oligonucleotide Synthesis Introduction
11.1.4 Genescript Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
11.1.5 Genescript Recent Development
11.2 GeneArt (Thermofischer)
11.2.1 GeneArt (Thermofischer) Company Detail
11.2.2 GeneArt (Thermofischer) Business Overview
11.2.3 GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Introduction
11.2.4 GeneArt (Thermofischer) Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
11.2.5 GeneArt (Thermofischer) Recent Development
11.3 Renesas Electronics Corporation
11.3.1 Renesas Electronics Corporation Company Detail
11.3.2 Renesas Electronics Corporation Business Overview
11.3.3 Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Introduction
11.3.4 Renesas Electronics Corporation Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
11.3.5 Renesas Electronics Corporation Recent Development
11.4 DNA 2.0 (ATUM)
11.4.1 DNA 2.0 (ATUM) Company Detail
11.4.2 DNA 2.0 (ATUM) Business Overview
11.4.3 DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Introduction
11.4.4 DNA 2.0 (ATUM) Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
11.4.5 DNA 2.0 (ATUM) Recent Development
11.5 OriGene
11.5.1 OriGene Company Detail
11.5.2 OriGene Business Overview
11.5.3 OriGene Solid-phase Oligonucleotide Synthesis Introduction
11.5.4 OriGene Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
11.5.5 OriGene Recent Development
11.6 BBI
11.6.1 BBI Company Detail
11.6.2 BBI Business Overview
11.6.3 BBI Solid-phase Oligonucleotide Synthesis Introduction
11.6.4 BBI Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
11.6.5 BBI Recent Development
11.7 Genewiz
11.7.1 Genewiz Company Detail
11.7.2 Genewiz Business Overview
11.7.3 Genewiz Solid-phase Oligonucleotide Synthesis Introduction
11.7.4 Genewiz Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
11.7.5 Genewiz Recent Development
11.8 Eurofins Genomics
11.8.1 Eurofins Genomics Company Detail
11.8.2 Eurofins Genomics Business Overview
11.8.3 Eurofins Genomics Solid-phase Oligonucleotide Synthesis Introduction
11.8.4 Eurofins Genomics Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
11.8.5 Eurofins Genomics Recent Development
11.9 Gene Oracle
11.9.1 Gene Oracle Company Detail
11.9.2 Gene Oracle Business Overview
11.9.3 Gene Oracle Solid-phase Oligonucleotide Synthesis Introduction
11.9.4 Gene Oracle Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
11.9.5 Gene Oracle Recent Development
11.10 SBS Genetech
11.10.1 SBS Genetech Company Detail
11.10.2 SBS Genetech Business Overview
11.10.3 SBS Genetech Solid-phase Oligonucleotide Synthesis Introduction
11.10.4 SBS Genetech Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
11.10.5 SBS Genetech Recent Development
11.11 Bio Basic
11.11.1 Bio Basic Company Detail
11.11.2 Bio Basic Business Overview
11.11.3 Bio Basic Solid-phase Oligonucleotide Synthesis Introduction
11.11.4 Bio Basic Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
11.11.5 Bio Basic Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Primers
Table 3. Key Players of Probes
Table 4. Key Players of Intermediate-scale Synthesis Oligos
Table 5. Key Players of Large-scale Synthesis Oligos
Table 6. Key Players of Linkers and Adaptors
Table 7. Global Solid-phase Oligonucleotide Synthesis Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Solid-phase Oligonucleotide Synthesis Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Solid-phase Oligonucleotide Synthesis Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Solid-phase Oligonucleotide Synthesis Market Share by Region (2018-2023)
Table 11. Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Solid-phase Oligonucleotide Synthesis Market Share by Region (2024-2033)
Table 13. Solid-phase Oligonucleotide Synthesis Market Trends
Table 14. Solid-phase Oligonucleotide Synthesis Market Drivers
Table 15. Solid-phase Oligonucleotide Synthesis Market Challenges
Table 16. Solid-phase Oligonucleotide Synthesis Market Restraints
Table 17. Global Solid-phase Oligonucleotide Synthesis Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Solid-phase Oligonucleotide Synthesis Market Share by Players (2018-2023)
Table 19. Global Top Solid-phase Oligonucleotide Synthesis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid-phase Oligonucleotide Synthesis as of 2022)
Table 20. Ranking of Global Top Solid-phase Oligonucleotide Synthesis Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Solid-phase Oligonucleotide Synthesis Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Solid-phase Oligonucleotide Synthesis Product Solution and Service
Table 24. Date of Enter into Solid-phase Oligonucleotide Synthesis Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Solid-phase Oligonucleotide Synthesis Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Type (2018-2023)
Table 28. Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Type (2024-2033)
Table 30. Global Solid-phase Oligonucleotide Synthesis Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Application (2018-2023)
Table 32. Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Application (2024-2033)
Table 34. North America Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Solid-phase Oligonucleotide Synthesis Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Solid-phase Oligonucleotide Synthesis Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Solid-phase Oligonucleotide Synthesis Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Solid-phase Oligonucleotide Synthesis Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Country (2024-2033) & (US$ Million)
Table 49. Genescript Company Detail
Table 50. Genescript Business Overview
Table 51. Genescript Solid-phase Oligonucleotide Synthesis Product
Table 52. Genescript Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)
Table 53. Genescript Recent Development
Table 54. GeneArt (Thermofischer) Company Detail
Table 55. GeneArt (Thermofischer) Business Overview
Table 56. GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Product
Table 57. GeneArt (Thermofischer) Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)
Table 58. GeneArt (Thermofischer) Recent Development
Table 59. Renesas Electronics Corporation Company Detail
Table 60. Renesas Electronics Corporation Business Overview
Table 61. Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Product
Table 62. Renesas Electronics Corporation Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)
Table 63. Renesas Electronics Corporation Recent Development
Table 64. DNA 2.0 (ATUM) Company Detail
Table 65. DNA 2.0 (ATUM) Business Overview
Table 66. DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Product
Table 67. DNA 2.0 (ATUM) Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)
Table 68. DNA 2.0 (ATUM) Recent Development
Table 69. OriGene Company Detail
Table 70. OriGene Business Overview
Table 71. OriGene Solid-phase Oligonucleotide Synthesis Product
Table 72. OriGene Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)
Table 73. OriGene Recent Development
Table 74. BBI Company Detail
Table 75. BBI Business Overview
Table 76. BBI Solid-phase Oligonucleotide Synthesis Product
Table 77. BBI Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)
Table 78. BBI Recent Development
Table 79. Genewiz Company Detail
Table 80. Genewiz Business Overview
Table 81. Genewiz Solid-phase Oligonucleotide Synthesis Product
Table 82. Genewiz Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)
Table 83. Genewiz Recent Development
Table 84. Eurofins Genomics Company Detail
Table 85. Eurofins Genomics Business Overview
Table 86. Eurofins Genomics Solid-phase Oligonucleotide Synthesis Product
Table 87. Eurofins Genomics Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)
Table 88. Eurofins Genomics Recent Development
Table 89. Gene Oracle Company Detail
Table 90. Gene Oracle Business Overview
Table 91. Gene Oracle Solid-phase Oligonucleotide Synthesis Product
Table 92. Gene Oracle Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)
Table 93. Gene Oracle Recent Development
Table 94. SBS Genetech Company Detail
Table 95. SBS Genetech Business Overview
Table 96. SBS Genetech Solid-phase Oligonucleotide Synthesis Product
Table 97. SBS Genetech Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)
Table 98. SBS Genetech Recent Development
Table 99. Bio Basic Company Detail
Table 100. Bio Basic Business Overview
Table 101. Bio Basic Solid-phase Oligonucleotide Synthesis Product
Table 102. Bio Basic Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)
Table 103. Bio Basic Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Solid-phase Oligonucleotide Synthesis Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Solid-phase Oligonucleotide Synthesis Market Share by Type: 2022 VS 2033
Figure 3. Primers Features
Figure 4. Probes Features
Figure 5. Intermediate-scale Synthesis Oligos Features
Figure 6. Large-scale Synthesis Oligos Features
Figure 7. Linkers and Adaptors Features
Figure 8. Global Solid-phase Oligonucleotide Synthesis Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Solid-phase Oligonucleotide Synthesis Market Share by Application: 2022 VS 2033
Figure 10. Commercial Case Studies
Figure 11. Academic Research Case Studies
Figure 12. Solid-phase Oligonucleotide Synthesis Report Years Considered
Figure 13. Global Solid-phase Oligonucleotide Synthesis Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Solid-phase Oligonucleotide Synthesis Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Solid-phase Oligonucleotide Synthesis Market Share by Region: 2022 VS 2033
Figure 16. Global Solid-phase Oligonucleotide Synthesis Market Share by Players in 2022
Figure 17. Global Top Solid-phase Oligonucleotide Synthesis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid-phase Oligonucleotide Synthesis as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Solid-phase Oligonucleotide Synthesis Revenue in 2022
Figure 19. North America Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Solid-phase Oligonucleotide Synthesis Market Share by Country (2018-2033)
Figure 21. United States Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Solid-phase Oligonucleotide Synthesis Market Share by Country (2018-2033)
Figure 25. Germany Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Share by Region (2018-2033)
Figure 33. China Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Solid-phase Oligonucleotide Synthesis Market Share by Country (2018-2033)
Figure 41. Mexico Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Share by Country (2018-2033)
Figure 45. Turkey Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Genescript Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
Figure 48. GeneArt (Thermofischer) Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
Figure 49. Renesas Electronics Corporation Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
Figure 50. DNA 2.0 (ATUM) Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
Figure 51. OriGene Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
Figure 52. BBI Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
Figure 53. Genewiz Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
Figure 54. Eurofins Genomics Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
Figure 55. Gene Oracle Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
Figure 56. SBS Genetech Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
Figure 57. Bio Basic Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed